Mimedx (MDXG) FCF Margin (2011 - 2026)

Mimedx has disclosed FCF Margin across 16 years of filings, most recently posting 2.22% for Q1 2026.

• FCF Margin for Q1 2026 came in at 2.22%, down 336.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 17.81% (down 79.0% YoY), and the FY2025 annual result was 17.43%, down 133.0% from the prior year.
• FCF Margin came in at 2.22% for Q1 2026 at Mimedx, down from 20.89% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 25.96% in Q2 2024 to a low of 17.56% in Q1 2022.
• The 5-year median for FCF Margin is 9.2% (2023), against an average of 9.15%.
• Across the five-year window, FCF Margin soared 2741 bps in 2022 and plunged 1152 bps in 2025, its largest moves.
• Mimedx's FCF Margin stood at 4.88% in 2022, then surged by 95 bps to 9.52% in 2023, then soared by 120 bps to 20.93% in 2024, then slipped by 0 bps to 20.89% in 2025, then tumbled by 89 bps to 2.22% in 2026.
• The last three FCF Margin figures came in at 2.22% (Q1 2026), 20.89% (Q4 2025), and 25.62% (Q3 2025), per Business Quant data.